Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma
Douwe Postmus(University Medical Center Groningen), Francesco Pignatti, Sarah Richard(Myeloma UK), Hans L. Hillege(University Medical Center Groningen), Gert van Valkenhoef(University Medical Center Groningen), Isabelle Moulon, Tomas Salmonsson(Medical Products Agency), Nathalie Bere, Maria Mavris(European Union), Eric Low(Myeloma UK), Beatriz Flores, Jayne Galinsky(Myeloma UK)
Cited by 63
Related Papers
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma
|British Journal of Haematology|2004|447
Guidelines for the diagnosis and management of multiple myeloma 2011
|British Journal of Haematology|2011|305
Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic Dysfunction
|Circulation|2006|296
The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF Study
|European Journal of Heart Failure|2019|281